In India's vast private healthcare system, a new nationwide study has revealed that more than half of all tuberculosis prescriptions fall short of established medical protocols — amounting to over two million flawed treatments issued every year. Since the majority of TB patients in India first seek private care, this systemic prescribing failure places millions of vulnerable people at heightened risk of treatment failure and drug-resistant infection. The finding lays bare a long-suspected gap between national elimination ambitions and the fragmented reality of private medical practice. It is a
Over Half of Private TB Prescriptions in India Found Faulty, Fueling Drug Resistance
Faulty TB prescriptions reduce recovery chances and increase drug-resistant TB risk, directly impacting millions of patients seeking private treatment across India.